Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson's disease.

The Journal of neuroscience : the official journal of the Society for Neuroscience

Volumn 21, Issue 10, 2001, Pages

  Chen, J F ^a   Xu, K ^a   Petzer, J P ^a   Staal, R ^a   Xu, Y H ^a   Beilstein, M ^a   Sonsalla, P K ^a   Castagnoli, K ^a   Castagnoli Jr , N ^a   Schwarzschild, M A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 1,3-DIPROPYL-8-CYCLOPENTYLXANTHINE; 3,4 DIHYDROXYPHENYLACETIC ACID; 3,7 DIMETHYL 1 PROPARGYLXANTHINE; 3,7-DIMETHYL-1-PROPARGYLXANTHINE; 5 AMINO 2 (2 FURYL) 7 (2 PHENYLETHYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE A2A RECEPTOR; ADENOSINE RECEPTOR; CAFFEINE; CATECHOL DERIVATIVE; DOPAMINE; DRUG DERIVATIVE; ISTRADEFYLLINE; NEUROPROTECTIVE AGENT; PURINE DERIVATIVE; PYRIMIDINE DERIVATIVE; THEOBROMINE; TRIAZOLE DERIVATIVE; XANTHINE DERIVATIVE;

ANIMAL; ARTICLE; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; CORPUS STRIATUM; DISEASE MODEL; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; INNATE IMMUNITY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; METABOLISM; MOUSE; MOUSE MUTANT; PARKINSONISM; PATHOLOGY;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; 3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; CAFFEINE; CATECHOLS; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; IMMUNITY, NATURAL; INJECTIONS, INTRAPERITONEAL; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUROPROTECTIVE AGENTS; PARKINSONIAN DISORDERS; PURINES; PYRIMIDINES; RECEPTOR, ADENOSINE A2A; RECEPTORS, PURINERGIC P1; THEOBROMINE; TRIAZOLES; XANTHINES;

EID: 0035874345     PISSN: None     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/jneurosci.21-10-j0001.2001     Document Type: Article

References (0)